Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)

The summary for the Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed): The purpose of this Funding Opportunity Announcement (FOA) is to advance the experimental validation and functional characterization of genetic variants in coding or non-coding genomic regions that result in inborn errors of immunity/primary immunodeficiency diseases and to elucidate the molecular, cellular, and immunological mechanisms of these disorders. Understanding the genetic basis of primary immunodeficiency disorders is essential for their diagnosis, prognosis, and the development of precision therapeutics.
Federal Grant Title: Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-19-078
Type of Funding: Grant
CFDA Numbers: 93.855
CFDA Descriptions: Information not provided
Current Application Deadline: January 7th, 2022
Original Application Deadline: January 7th, 2022
Posted Date: November 26th, 2018
Creation Date: November 26th, 2018
Archive Date: February 12th, 2022
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: November 26th, 2018
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-19-078.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed)
HIV/AIDS Clinical Trials Units (UM1 Clinical Trial Required)
Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (U01 Clinical T...
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human...
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human...
Center for HIV/AIDS Vaccine Immunology (CHAVI)
Genomics of Transplantation Cooperative Research Program
Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health
Drug Screening with Biofabricated 3-D Skin Disease Tissue Models (U18 Clinical Trial Not A...
Postdoctoral Research Associate Training (PRAT) Program (Fi2)
Methods to Improve Reproducibility of Human iPSC Derivation, Growth and Differentiation (S...
Sponsored Programs Administration Development (SPAD) Program (UC2 - Clinical Trial Not All...
PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com